Some news could be coming about these:
Commence evaluation of BARD1-Breast and BARD1-Lung cancer tests on Luminexplatform (2H CY20) ASX: 14 Nov 2019
The Company expects to initiate research programs by the end of December 2020 with the objective of building a range of proprietary new SubB2M assays combined with existing and/or novel cancer biomarkers to develop highly specific tests for screening and treatment monitoring of various cancers. ASX: 3 Sep 2020·
Ann: Successful BARD1 Kit Evaluation, page-54
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.020(3.42%) |
Mkt cap ! $62.30M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 57.5¢ | 56.5¢ | $21.90K | 38.41K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4193 | 56.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 15.33pm 11/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |